Brain oxygen study in kids with sickle cell disease halted early
NCT ID NCT05018728
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 19 times
Summary
This study looked at whether the drug voxelotor can improve brain blood flow and oxygen use in children with sickle cell anemia. Researchers planned to measure these effects in 22 participants aged 4 to 30 years. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL ANEMIA IN CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aflac Sickle Cell Comprehensive Clinics at Children's Healthcare of Atlanta, Scottish Rite
Atlanta, Georgia, 30342, United States
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.